Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.41 |
| ▸ | ACHE | P22303 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19037380 | 0.83 | KMT2A (0.54) | KMT2APABPC1KDM4EHSP90AA1ACHE | |
| Hydrochloric Acid SCHEMBL19031444 | 0.81 | KMT2A (0.52) | KMT2APABPC1KDM4EHSP90AA1ACHE | |
| SCHEMBL171879 | 0.78 | KMT2A (0.54) | KMT2APABPC1KDM4EHSP90AA1ACHE | |
| Iodide SCHEMBL11884469 | 0.76 | KMT2A (0.52) | KMT2APABPC1KDM4EHSP90AA1ACHE | |
| Hydrochloric Acid SCHEMBL344009 | 0.76 | KMT2A (0.52) | KMT2APABPC1KDM4EHSP90AA1ACHE | |
| SCHEMBL15571880 | 0.76 | KMT2A (0.52) | KMT2APABPC1KDM4EHSP90AA1ACHE | |
| SCHEMBL15571863 | 0.76 | KMT2A (0.52) | KMT2APABPC1KDM4EHSP90AA1ACHE | |
| SCHEMBL15571321 | 0.76 | KMT2A (0.52) | KMT2APABPC1KDM4EHSP90AA1ACHE | |
| Bromide SCHEMBL11429835 | 0.76 | KMT2A (0.58) | KMT2APABPC1KDM4EHSP90AA1ACHE | |
| SCHEMBL15571095 | 0.76 | KMT2A (0.52) | KMT2APABPC1KDM4EHSP90AA1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9895470-B2 | Non-fouling, anti-microbial, anti-thrombogenic graft—from compositions | SEMPRUS BIOSCIENCES CORP. (US) | 2018-02-20 | — | — | US | disclosed |
| US-20160118155-A1 | CONDUCTIVE PASTE, METHOD OF PRODUCING CONDUCTIVE PATTERN, AND TOUCH PANEL | TORAY INDUSTRIES, INC. (JP) | 2016-04-28 | — | — | US | disclosed |
| US-20120124703-A1 | NOVEL COPRINUS COMATUS AND TREMELLA MESENTERICA MUSHROOM STRAINS, PRODUCTS AND EXTRACTS THEREOF AND COMPOSITIONS COMPRISING THEM | PALMED TEVA LTD (IL) | 2012-05-17 | — | — | US | disclosed |
| EP-2405923-A1 | NOVEL COPRINUS COMATUS AND TREMELLA MESENTERICA MUSHROOM STRAINS, PRODUCTS AND EXTRACTS THEREOF AND COMPOSITIONS COMPRISING THEM | Palmed Teva Ltd (IL) | 2012-01-18 | — | — | EP | disclosed |
| WO-2010103519-A1 | NOVEL COPRINUS COMATUS AND TREMELLA MESENTERICA MUSHROOM STRAINS, PRODUCTS AND EXTRACTS THEREOF AND COMPOSITIONS COMPRISING THEM | PALMED TEVA LTD (IL) | 2010-09-16 | — | — | WO | disclosed |
| EP-1592804-A4 | HIGH SPEED ASSAY FOR GLYCOSYL TRANSFERASES | MERCK & CO INC (US) | 2007-08-22 | — | — | EP | disclosed |
| US-20060147934-A1 | High speed assay for glycosyl transferases | ANDERSON MATT S | 2006-07-06 | — | — | US | disclosed |
| EP-1592804-A2 | HIGH SPEED ASSAY FOR GLYCOSYL TRANSFERASES | Merck & Co., Inc. (US) | 2005-11-09 | — | — | EP | disclosed |
| WO-2004072607-A2 | HIGH SPEED ASSAY FOR GLYCOSYL TRANSFERASES | MERCK & CO. INC. (US) | 2004-08-26 | — | — | WO | disclosed |
| EP-0752465-A1 | Betaine esters for delivery of alcohols | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-08 | — | — | EP | disclosed |
| WO-1996038528-A1 | BETAINE ESTERS FOR DELIVERY OF ALCOHOLS | THE PROCTER & GAMBLE COMPANY (US) | 1996-12-05 | — | — | WO | disclosed |
| WO-1995001181-A1 | HYALURONIC ACID FRAGMENTS AND THEIR THERAPEUTIC USE | ALLELIX BIOPHARMACEUTICALS INC. (CA) | 1995-01-12 | — | — | WO | disclosed |
| US-5192661-A | Cancer diagnosis | UNIVERSITY OF OTTAWA (CA) | 1993-03-09 | — | — | US | disclosed |
| US-5034516-A | Compounds for diagnosing cancer | UNIVERSITY OF OTTAWA (CA) | 1991-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120124703-A1 | NOVEL COPRINUS COMATUS AND TREMELLA MESENTERICA MUSHROOM STRAINS, PRODUCTS AND EXTRACTS THEREOF AND COMPOSITIONS COMPRISING THEM | MANBA, FUCA1, FUCA2 | KMT2A 2661/4885PABPC1 2658/4885KDM4E 4050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.